Molecular targets of tyrosine kinase inhibitors in thyroid cancer
Poupak Fallahi, Silvia Martina Ferrari, Maria Rosaria Galdiero, Gilda Varricchi, Giusy Elia, Francesca Ragusa, Sabrina Rosaria Paparo, Salvatore Benvenga, Alessandro Antonelli
Topics & Concepts
VandetanibMedicineLenvatinibThyroid cancerSorafenibCancerCabozantinibCancer researchInternal medicineAnaplastic thyroid cancerMedullary thyroid cancerTyrosine kinaseThyroglobulinOncologyAngiogenesisReceptor tyrosine kinaseVascular endothelial growth factorThyroidReceptorHepatocellular carcinomaVEGF receptorsThyroid Cancer Diagnosis and TreatmentCoagulation, Bradykinin, Polyphosphates, and Angioedema